Combination of liquid biopsy and PET/CT enhances prediction of pathological response to neoadjuvant immunochemotherapy in patients with esophageal squamous cell carcinoma

被引：0
|
作者：
Yang, Weixiong
Fang, Zengli
Wang, Xiaoyan
Luo, Hui
Zhang, Shuishen
Zeng, Bo
Liu, Zhenguo
Wang, Chenxuan
Ou, Qiuxiang
Yang, Lingling
Tang, Haimeng
Yeung, Sai-Ching J.
Cheng, Chao
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-6412
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6412
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Esophageal squamous cell carcinoma transformed into neuroendocrine carcinoma after neoadjuvant immunochemotherapy: A case report
    Xin, Gaojie
    Song, Naicheng
    Jiang, Ke
    ONCOLOGY LETTERS, 2024, 27 (04)
  • [22] Patterns of recurrence after esophagectomy following neoadjuvant immunochemotherapy in patients with thoracic esophageal squamous cell carcinoma
    An, Qiuying
    Zhang, Ping
    Wang, Hongyan
    Zhang, Zihan
    Liu, Sihan
    Bai, Wenwen
    Zhu, Hui
    Zhen, Chanjun
    Qiao, Xueying
    Yang, Liwei
    Wang, Yajing
    Wang, Jun
    Liu, Yibing
    Si, Hanyu
    Su, Yuhao
    Xu, Xiaoli
    Yang, Fan
    Zhou, Zhiguo
    EJSO, 2025, 51 (03):
  • [23] Modeling Radiosensitivity with Gene Interactions Improves the Prediction of Pathological Response to Neoadjuvant Concurrent Chemoradiation in Esophageal Squamous Cell Carcinoma
    Hsu, F. M.
    Cheng, J. C. H.
    Hsu, C. H.
    Chang, Y. L.
    Lee, J. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E451 - E452
  • [24] Single-cell sequencing reveals immune features of treatment response to neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma
    Yang, Zhenlin
    Tian, He
    Chen, Xiaowei
    Li, Bozhao
    Bai, Guangyu
    Cai, Qingyuan
    Xu, Jiachen
    Guo, Wei
    Wang, Shuaibo
    Peng, Yue
    Liang, Qing
    Xue, Liyan
    Gao, Shugeng
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [25] Patterns of recurrence after esophagectomy following neoadjuvant Immunochemotherapy for esophageal squamous cell carcinoma
    An, Qiuying
    Zhang, Ping
    Bai, Wenwen
    Zhen, Chanjun
    Liu, Sihan
    Ji, Hongshan
    Zhang, Zihan
    Fu, Liyuan
    Wang, Jun
    Wang, Hongyan
    Liu, Qingyi
    Zhu, Hui
    Wang, Yajing
    Su, Yuhao
    Si, Hanyu
    Jia, Yage
    Zhou, Zhiguo
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [26] Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma Incorporating Hematological Biomarkers
    Wu, Yingji
    Chen, Jinbin
    Zhao, Lei
    Li, Qiaoqiao
    Zhu, Jinhan
    Yang, Hong
    Guo, Suping
    Xi, Mian
    CANCER RESEARCH AND TREATMENT, 2021, 53 (01): : 172 - 183
  • [27] A Transcriptomic Liquid Biopsy Assay for Predicting Resistance to Neoadjuvant Therapy in Esophageal Squamous Cell Carcinoma
    Okuno, Keisuke
    Tokunaga, Masanori
    Kinugasa, Yusuke
    Baba, Hideo
    Kodera, Yasuhiro
    Goel, Ajay
    ANNALS OF SURGERY, 2022, 276 (01) : 101 - 110
  • [28] A Novel Predictor of Pathologic Complete Response for Neoadjuvant Immunochemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
    Yang, Yalan
    Xin, Dao
    Wang, Huike
    Guan, Lulu
    Meng, Xiangrui
    Lu, Taiying
    Bai, Xiwen
    Wang, Feng
    JOURNAL OF INFLAMMATION RESEARCH, 2023, 16 : 1443 - 1455
  • [29] TRAIL expression in tumor cells predicts and drives poor response to neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma
    Yang, Weixiong
    Wang, Fang
    Guo, Jianping
    Cai, Junchao
    Wang, Zekang
    Liu, Yao
    Fang, Zengli
    Chen, Wenfang
    Xu, Lixia
    Zhang, Shuishen
    Zeng, Bo
    Liu, Zhenguo
    Peng, Sui
    Yeung, Sai-Ching Jim
    Cheng, Chao
    CANCER RESEARCH, 2024, 84 (06)
  • [30] Prediction of lymph node metastasis by PET/CT metabolic parameters in patients with esophageal squamous cell carcinoma
    Xu, Manman
    Wang, Ling
    Ouyang, Mingli
    Lin, Jie
    Wang, Lili
    Zheng, Xiangwu
    Miao, Shouliang
    Tang, Kun
    NUCLEAR MEDICINE COMMUNICATIONS, 2019, 40 (09) : 933 - 939
12345